Esendo Fungicide will be the first combination product that AgBiome brings to market and its third product in the last four years.
AgBiome, a leader in developing innovative products from the Earth’s microbial communities, has announced the submission of Esendo Fungicide, its next product, to the EPA for review. Pending EPA registration, Esendo Fungicide will be the first combination product that AgBiome brings to market and its third product in the last four years.
Esendo Fungicide is a premix that combines Howler Fungicide with the active ingredient azoxystrobin. The combination has multiple modes of action for resistance management and provides activity against a broad spectrum of important diseases. Esendo Fungicide can be used effectively as part of an integrated disease and resistance management program on a wide range of important crops.
“AgBiome continues to develop highly-effective, innovative crop protection products. Growers need new tools to control problematic diseases while ensuring effective resistance management. Esendo Fungicide provides growers access to the combined power of the biological benefits of Howler and a proven synthetic chemistry,” said Dr Jim Spadafora, Project Lead at AgBiome
Esendo fungicide will mark AgBiome’s third fungicide submitted to the EPA to date. AgBiome has developed two biological fungicides, Howler and Theia Fungicide. Howler received EPA approval in the second half of 2017, and has gained individual registration in all 50 US states. Theia Fungicide was submitted for EPA review in December 2019.
